0817 Dragonfly BMS
BioCentury & Getty Images


Dragonfly’s TrinKET-enhancing cytokine platform sees early win with $475M BMS deal 

Aug 18, 2020 | 2:16 AM GMT

Dragonfly has struck another deal with BMS for nearly half a billion dollars up front covering a clinical IL-12 program designed to complement its NK

Read the full 494 word article

How to gain access

Continue reading with a
two-week free trial.